throbber
DISPENSING OF
`MEDICATION
`
`Formerly HuscI's Pharmaceutical Dispensing
`
`A Manual on the Formulation of Pharmaceutical Products,
`the Dispensing of Prescriptions, and
`The Professional Practice of Pharmacy
`
`EDITOR
`
`ERIC W. MARTIN PhC,B3c,MS,PhD,
`
`Adjunct Pzufesso): of Biomedical Communicefion, Columbia Univermity
`College of Pharmaceutical Sciences; Director of Medical Commlmication,
`Lederrle Lnbmainriea, Division of Amazixmn Cyanamid Company. Formerly
`Editor, Jofimd of
`the American PM Association, Emecufive
`Eclibor, Pfize:’s Spectrum, Eclihm-in-Chief, Remington's Phannaoeutfml
`Sciances; flutbor of TEeIr.mLqu£-.s of Meflimfiorg Hamrds of Medimtiarg and
`some 80 01:116.’ biomedical publications; licensed p in Canada and
`the United States; Founder: and finzt Preaidantlz, Drug Inforniation Aaaocinu
`tion; President, American Medical Wflbem Asaendafion, 19'?0—-1971; Fellow
`AAAS, American Medical Wfibem Aaaudafiom, and Internafianfll Academy
`of Law and Science, etc.
`
`SEVENTH EDITION
`
`211.:-.'.=.«x
`
`
`
`
`
`Amerigen Ex. 1060, p. 1
`Amerigen Ex. 1060, p.
`
`MACK PUBLISHING COMPANY
`
`
`
`1971
`
`

`
`
`
`
`
`©Copyright1971by
`
`MACK PUBLISIIING COMPANY
`Easton, Pennsylvania
`
`All Rights Reserved
`This book or any part thereof must
`not be reproduced in any form without the
`written permission of the publisher.
`
`Printed in the United States of America
`
`LibraryofCongrewCatalogCardNumber:
`
`'?{)—165831
`
`I ‘
`
`1'
`
`I ‘
`
`I
`
`Amerigen Ex. 1060, p. 2
`
`

`
`
`
`
`
`
`
`CHAPTER 20
`
`
`Cooling
`
`
`
`Chapter preparation by
`James R. Mccowan, PhD
`Professor of Pharmaceutics
`School of Pharmacy
`University of Arkansas, Medical Center
`Little Rock, Arkasusae 72201
`
`The coating of pills has been performed
`since antiquity, and with the advent of
`tablets and capsules, methods have been
`devised for coating these dosage forms
`also.
`
`Tablets and caps_ules may be coated
`for various reasons:
`to protect the in-
`gredients from light or air to insure
`stability of the medicinal, to mask an
`objectionable taste or odor, or to improve
`the appearance of
`the dosage form.
`Such coatings readily disintegrate or
`dissolve in the stomach and are not in-
`
`the activity of the
`tended to alfect
`medicinal
`following
`administration.
`Coatings used to mask taste and odor or
`to improve appearance are primarily
`used to gain patient acceptance of the
`dosage form.
`-
`A special type of coating, referred to
`as an anteric coating, may be applied to
`tablets and capsules. Coatings of this
`type do not disintegrate in the stomach
`but will disintegrate or dissolve in the
`intestinal fluids. Enteric coating may be
`utilized to control the site of drug re-
`lease,
`to protect
`the activity of the
`medicinal from the gastric pH or
`to
`
`812
`
`prevent nausea or gastric irritation
`caused by the uncoated medicinal.
`Various techniques and coating ma-
`terials may he employed to allow the
`medicinal to be released from the tablet
`
`in such a manner as to give a delayed
`action, a repeat action, or a sustained
`action. Compression coating, or dry
`coating, may be utilized to prevent
`incompatibilities by putting one drug in
`a tablet core and compressing a dry
`coating containing another drug around
`the tablet core. Products of this type are
`frequently referred to as
`a “tablet
`within a tablet.” Repeat action or sus-
`tained action may also be obtained with
`compression coating.
`
`1
`
`Butisol Sodium R.A- (McNeil)
`D.T.D. No. 21
`Sig: One three times a day
`
`30 mg
`
`2
`
`. No. 100
`Pabirin Buffered tablets (Dorsey)
`Sig: Two tablets every four hours
`
`Fig ED-l—S‘to kes’ tz
`
`Sugar Cooling
`
`Probably thi
`coating for
`ta
`scale is a sugar
`sive thin layeri
`are applied to 1
`and tumble in
`
`3
`Q
`
`;
`
`pans are avail:
`shapes but are
`sels, usually m:
`steel and are I
`shaft so thatth 5
`Polishing pane
`pans that have
`they may be
`sugar coating :
`by adding the
`tion or suspens
`
`equipped with
`cold air throu
`
`drying. Exhau
`move moisture
`See Fig 20-1 tc
`Tablets whi
`made with con
`
`a spherical sh
`diflicult to coa
`should be re:
`
`placed in the (
`The usual s
`
`(1) waterprooi
`of moisture in
`
`ing to fill out
`(3) smooth cu
`smooth surfac
`
`___:!__Mf_‘a____-flu2”,gl‘TMwk,2_:_W_,,,,__?!,,,,,._._,I,’,,,,,,I{,,,,‘,_..:.,_..._.._......_._-_._.:._._.,w.._...-,.'-...»._»..-....¢-.,.-an-9.\—1«'>AI6.v__-;_-‘4\.o.-\_«5~z--_-:40‘?-I.-L
`
`
`
`
`
`
`Amerigen Ex. "106 1 p. 3
`Amerigen Ex. 1060, p. 3
`
`

`
`
`
`
`Coating
`
`813
`
`to obtain the desired color, and (5) pol-
`ishing to give the finished product a high
`gloss.
`Waterproofing—Since the vehicle for
`sugar coating is water, most tablets re-
`quire an initial sealing coat to prevent
`moisture from penetrating the tablet and
`destroying the ingredients of the tablet.
`This is accomplished by applying one or
`two coats ocli arsenic-free shellac, cellulose
`derivatives such as ethylcellulose, or sili~
`cones. Waterpmofing materials must be
`applied sparingly since excess material
`may retard disintegration time of the
`coating and even result in an unwanted
`enteric coating.
`Subcoating——As the tablets rotate
`in the coating pan, a heavy syrup usually
`containing acacia and sugar in water is
`added The tablets should tumble freely
`in the pan until they become sticky. A
`dusting powder consisting of starch and
`powdered sugar is then applied and rota-
`tion of the pan is continued until the tab-
`lets have dried. Precipitated chalk, pow-
`dered acacia or talc may also be added to
`the subcoating powder. The process of
`adding the solution and powder is re-
`peated until the edges of the tablets are
`sufficiently covered and rounded.
`SmootI1iI1g—Following subcoating, a
`heavy sugar syrup is added to the tablets
`rotating in the pan. The smoothing
`syrup is added slowly to moisten the
`tablets and warm air is used to hasten
`drying. _A dusting powder may or may
`
`
`
`Abbott
`
`Fig 20-2—Tab'|et coating pans.
`
`H;
`
`.
`Amerigen Ex. 106i), p
`Amerigen Ex. 1060, p. 4
`4i:
`EU:I:.
`lS
`.
`
`Fig 20-1—~Stokes' tablet coating pans.
`
`Sugar Coating
`
`Probably the most commonly used
`coating for
`tablets on a commercial
`scale is a sugar coating in which succes-
`sive thin layers of the coating material
`are applied to the tablets as they rotate
`and tumble in the coating pan. Coating
`pans are available in various sizes and
`shapes but are essentially spherical ves-
`sels, usually made of copper or stainless
`steel and are mounted on the end of a
`
`shaft so that they may be made to rotate.
`Polishing pans frequently are coaiing
`pans that have been lined with canvas, or
`they may be canvas drums- Since the
`sugar coating of tablets is accomplished
`by adding the coating material in solu-
`tion or suspension form, coating pans are
`equipped with air blowers to force hot or
`cold air through the pans to facilitate
`drying. Exhaust ducts are used to re-
`move moisture and dust from the pans.
`See Fig 20-1 to 20-6.
`Tablets which are to be coated are
`
`made with convex surfaces approaching
`a spherical shape since flat tablets are
`difficult to coat. Dust and broken tablets
`should be removed before tablets are
`
`placed in the coating pan.
`The usual stages of coating consist of
`(1) waterproofing to prevent penetration
`of moisture into the tablet, (2) subcoat-
`ing to fill out and build up the tablets,
`(3) smooth coating to produce a hard
`smooth surface, (4) coloring and finishing
`
`

`
`
`
`814
`
`Coating
`
`not be used in conjunction with the
`syrup. A sufficient number of coats are
`applied to give a smooth surface and to
`build the tablets to a specific size.
`CoIoring—To avoid a mottled ap-
`pearanci, color is built up gradually by
`the use of diluted colored
`syrups.
`Colored syrups are made by dissolving
`certified water-soluble dyes in syrup and
`then several difierent dilutions of color
`
`are made by adding plain syrup to the
`colored syrup. Several coats of the light-
`est colored syrups are applied, then sev-
`eral coam of the next dilution are applied.
`The other dilutions are added in order,
`with the undiluted colored syrups being
`applied last. Drying is necessary between
`each coat and it is customary to dry the
`last coat very slowly by manually turn-
`ing the pan every few minutes to prevent
`the tablets from sticking together and to
`promote the slow drying.
`PoIishing—wAi'ter the coloring coats
`have been applied,
`the coated tablets
`are then polished by rotating them in the
`polishing pan with lulnps of wax or with
`‘the addition of a solution of the wax in a
`volatile solvent. See Fig 2041.
`Since in the standard sugar coating
`procedure much time is spent in sealing,
`rounding and smoothing the tablet and
`overcoming the white background during
`the coloring phase, a revised procedure
`has been advanced.‘ An undercoating ad—
`hesive suspension consisting essentially
`
`
`
`8'! Cor
`Fig 2fl—3—Weighing operation and polishing
`room.
`
`
`
`Lily
`Fig 2|]-4»-Tablet coating pans. Polishing pans
`are similar but are lined with canvas.
`
`of acacia, gelatin, sucrose and water is
`mixed with a stock coating formulation
`of dioctyl sodium sulfosuccinate,
`insol—
`uble coloring material, titanium dioxide,
`and syrup. This undercoatin g suspension
`is applied to the rotating tablets and fol-
`lowed by dusting of the tablets With pow-
`dered acacia. The procedure is repeated
`once- The tablets are then sealed with
`one coat of a material such as shellac and '
`
`are then Tnished by the application of
`approximately 25 coats of the stock coat~
`ing formulation diluted with coating
`syrup. The tablets are then polished in
`the usual fashion. With this procedure,
`colored coatings
`can be applied to
`the subcoating and the application of
`smoothing coats is eliminated.
`The process of tablet coating has long
`been recognized as an art dependent
`upon the experience and skill of the per—
`"i
`
`
`
`J States 00110
`Fig2{]~5—Coatingtablets at Wyeth Laboratories.
`
`-_....w.................l......v._----e--_-'«.~‘+--=r.-'-"‘"*'=‘."-"‘”‘)"‘1'?*'*""“1‘*’?"“”*“'3"“‘“
`
`
`
`
`-_._M:m.,.',,...r—.s.-....v\x.';...',,_,_:.‘.;w4,_._.u...::......«-V.-Wm.»-1»--:~.r»--.q--:-w>éw-rv.u--=-.-.x-
`
`
`
`...¢....a-...~.3......
`
`Amerigen Ex. 1060,
`Amerigen Ex. 1060, p. 5
`
`
`
`Fig 2!]-fi——Tabl
`the end of the
`from the table
`
`'
`
`sonnel. Hov
`been devise:
`cedures to 1'
`
`to
`formity,
`cycles and
`ables.’- 3
`
`Film Cc-aIi'
`
`A more re
`a soluble fil)
`or films are
`
`ing and smo
`coating tim
`terials may
`solution in
`and waterp
`coating is
`their origin
`original sizu
`with solubl-
`the use of 1
`titanium di
`
`

`
` Coating
`
`Of the materials for film coating, cellu-
`losic high polymers such as sodium car-
`boitymethylcellulose have been used to
`mask taste and odor effectively.‘ A suit-
`able coating can be obtained by the use
`of
`a polyethylene glycol, Carbowax
`6000,‘ and a combination of carboxy-
`methylcellulose and Carbowax 6000 has
`also been utilized to give a_ suitable coat-
`ing.° Film coating employs coating pans,
`such as those used for sugar coating, and
`the tablets are_ tumbled in the pan and
`the solution of the coating material is
`added to the tablets. The solution may
`be poured or sprayed onto the tumbling
`tablets.
`-
`
`Fig 20-6—TabIets are coated over a 16-hour period in theselarge, giohular,_5tain|ess steel pans, At‘
`the end of the process, each tablet has 35 layers which rneasure altogether about 0.025 in. thick
`from the tahIet‘s cent er.
`
`Pfizer
`
`
`
`
`
`sonnel. However, several methods have
`been devised for automated coating pro—
`cedures to improve batch to batch uni~
`formity,
`to give reproducible coating
`cycles and to reduce operator vari-
`ables.*- 3
`
`Film Coating
`
`A more recent type of coating employs
`a soluble film to coat tablets. Thin coats,
`or films are sufficient and since subcoat—
`
`ing and smooth coatings are unnecessary,
`coating time is quite rapid. Coating ma—
`terials may be applied to the tablets as a
`solution in volatile, anhydrous vehicles
`and waterproofing of the tablet prior to
`coating is unnecessary. Tablets retain
`their original shape and essentially the
`original size. The films may be colored
`with soluble dyes or rendered opaque by
`the use‘ of pigments or materials such as
`titanium dioxide.
`
`Compression Couiirig
`Compression coating is also referred
`to as “dry coating” since the coating in
`the form of a fine granulation is com-
`pressed around the tablet by punches.
`
`
`Amerigen Ex. 1060, p. 6
`Amerigen Ex. 1060, p’.
`
`

`
`
`
`-
`
`solubility in acid
`in"alkaline solutir
`contents are somi
`it is advantageo
`coating of such a
`tegration is not er
`alkalinity of the
`siderable evidenc
`nal contents ran
`7.9. To insure the
`tegrate soon afte g
`testine, some re
`enteric coated ta} 5
`
`_
`
`atapHaslowaé
`In addition to ‘-
`‘
`materials to ol
`other materials 1
`plish this purp
`slowly soluble, r
`enzymes in the
`cause the coatir
`
`passes through tl
`When a releas
`
`5
`
`period of time i
`tlon or repeat 2
`be prepared by 11'
`core tablet whic '
`soluble sugar
`I
`medicament
`f0]
`Another method
`obtain a sustai
`coating many SI
`cament with var ‘
`a certain amom
`leased at diiferei
`tinal tract. The
`

`
`.
`
`in these pellets :
`the pellet core I
`form which is sf
`as an initial cos
`
`are generally eil
`or compressed Ill
`
`Dexaroyl Spansul
`Dispense No
`Sig; Take one
`
`Coatings may
`laminated tabl
`structed with :
`medicament arc
`
`persed medicarr
`
`
`
`
`
`__‘__~____)__,___W.~_____'“__;,_._._,_,___,,_._,-__.‘_._.T,_..,_,.,...:........-........_..v_..—.---emu-__
`
`
`
`
`
`
`
`
`
`816
`
`Coating
`
`This method may be utilized when water;
`as used-in the sugar coating operation,
`causes decomposition or degradation of
`the tablet ingredients. Incompatible ma-
`terials may also be combined by placing
`one material in the core tablet, an inert
`material compressed on the core and a
`second coat containing the other incom-
`patible material may be compressed on
`the core and first coat. Repeat action or
`sustained action tablets may be pro-
`duced by coating the core tablet with an
`appropriate material-
`
`Compression coating may be applied
`by feeding previously compressed core
`tablets into the dies of a specially de-
`signed tablet press used as a coating ma-
`chine. Each die has previously received a
`measured amount of the coating ma-
`terial, the core tablet is fed onto this and
`another measured amount of coating ma-
`terial is fed into the die. The tablet is
`then compressed between the punches of
`the press. Compression coating may also
`be produced by coupling two or three tab-
`let presses together so that the first press
`produces the core tablet and transfers it
`to the second press which presses the
`coating material on the tablet. The
`coated tablet may then be transferred to
`a third press for the application of the
`second coating. See Fig 20-7.
`
`Air Suspension
`
`A rapid method of coating drug parti-
`cles of various sizes and shapes has been
`developed by Wurster.7 The process con-
`sists of supporting particles or tablets in
`a vertical column with an upwardly mov-
`ing airstream during which time the
`coating solution is sprayed onto the sus-
`pended particles. The coating chamber
`consists of a vertical column constricted
`_at the bottom and expanded at the top.
`Air velocity in the constricted area is
`suficiently strong so that tablets enter-
`ing this area are propelled upwards. In
`the upper, or expanded area,
`the air
`velocity is greatly decreased so that the
`velocity will not support the tablets and
`they fall to the bottom. of the chamber.
`
`Upgohn
`Fig 29-7--Pressure coater used in the manufac-
`ture cf 3: tablet within a tablet.
`
`This process may be used to apply
`various types of coating materials such
`as suspensions of insoluble materials in
`
`coating solutions as well as fi.lm—type
`coating materials dissolved in volatile-
`solvents. It is not readily adaptable to
`the typical sugar coating. Coating time
`with air suspension is very rapid and
`batch uniformity is readily achieved.
`
`Enieric Coating
`
`Dosage forms such as tablets that are
`to be enteric coated are processed in a
`manner dependent upon the material to
`be used. The general process for tablets
`includes waterproofing the tablet by
`coating with shellac in a coating pan and
`then adding the enteric coating material -
`to the rotating tablets to build up the
`coat. A sugar coating may be applied
`over the enteric coating. Some coating
`materials may be applied by other meth-
`ods such as spraying the coating material
`on the tablets or by air suspension.
`Formerly, materials used for enteric
`coating were selected because of their in-
`
`
`
`
`
`.-Fr-.*.'*-'*—--“'---.-'
`
`
`
`
`
`
`
`
`
`Amerigen Ex. 1060, p. 7
`Amerigen Ex.
`p. 7
`
`

`
`solubility in acid solution and solubility
`in alkaline solution. Since the intestinal
`contents are sometimes acid in reaction,‘
`it is advantageous to have an enteric
`_coating of such a composition that disin-
`tegration is not entirely 'lependent on the
`alkalinity of the intestinal juices. Con-
`siderable evidence indicates that -intesti-
`nal contents range from pH 3.6 to pH
`7.9. To insure that enteric coatings disin—
`te grate soon after reaching the small in-
`testine, some researchers“ believe that
`enteric coated tablets should disintegrate
`at a pH as low as 3.7.
`In addition to the use of pH dependent
`materials to obtain enteric coatings,
`other materials Inay be used to accom-
`plish this purpose because they are
`slowly soluble, undergo degradation by
`enzymes in the intestinal tract, or be-
`cause the coating may _be eroded as it
`passes through the intestinal tract.
`_
`When a release of medicament over a
`
`period of time is desired, sustained ac-
`tion or repeat action medications may
`be prepared by utilizing an enteric coated
`core tablet which is then coated with a
`soluble sugar coating containing the
`medicament
`for an immediate dose.
`Another method of utilizing coatings to
`obtain a sustained action consists of
`coating many small pellets of the medi-
`cament with Varying thicknesses so that
`a certain amount of medicament is re-
`leased at different locations in the intes-
`tinal tract. The medicament contained
`
`in these pellets may either be located in
`the pellet core or may be in a solution
`form which is applied to the pellet core
`as an initial coating. The coated pellets
`are generally either enclosed in capsules
`or compressed into tablets.
`3
`
`Dexamyl Spansules (SKI?)
`Dispense No. 28
`Sig: Take one capsule at breakfast
`
`No. 2
`
`Coatings may also be used to prepare
`laminated tablets,
`ie,
`a
`tablet
`con-
`structed with a coated,
`inner core of
`medicament around which a shell of dis-
`
`persed medicament is added. This type
`
`Coating
`
`817
`
`of tablet is designed to present an im~
`mediate release of the drug from the shell
`and a subsequent release from the core
`as the coating disintegrates or djssolVe3_
`4
`
`Pyribsrizainine Lontabs (Ciba)
`Dispense No. 20 '
`'
`Sig: One tablet a.1n. and at night
`
`150 mg
`
`For further information regarding sus-
`tained action medications, see Chapter
`2'? on Prolonged-Action Medications.
`
`Materials for Enieric Coating
`Scientific journals are a rich source of
`information concerning materials uged
`for the enteric coating of tablets and
`capsules. Many materials have been ob-
`tained from the field of synthetic or de-_
`rived" polymers. The student is advised to
`peruse the literature to advance beyond
`the scope of this text.
`is
`Shellac———'1‘his
`resinous material
`soluble in aqueous solutions whichlare
`alkaline but not
`in those which are
`neutral or acid. An alcoholic solution of
`
`arsenic—free shellac may be sprayed on
`tablets or capsules in a coating pan and
`the solvent evaporated by means of a
`current of
`A mixture of five parts of
`shellac and one part of castor oil dis-
`solved in alcohol has been used-” Arn-
`moniated shellac, as well‘ as combinations
`of shellac with other coating substances,
`gives effective coatings. Shellac is also
`used to waterproof tablets prior to sugar
`coating to prevent moisture in the syrups
`from reacting with the tablet and when
`used for this purpose, care must be exer.
`(zised to avoid forming an enteric coating
`on the tablets.
`
`Cellulose Acetate Phthalate (CAP)
`—-This coating material has been found
`to have considerable merit as an enteric
`coating and is used commercially for this
`purpose- It disintegrates due to.
`the
`hydrolytic effect of intestinal esterases,
`even when the intestinal contents are
`acid.“ It has been "found to withstand
`the action of artificial gastric juice for a
`long period of tinie but will readily disin-
`tegrate in intestinal juice.” Antonides
`
`Amerigen Ex. 1060, p. 8
`
`

`
`
`
`..._...¢-.....-.-......—...-.-.\..,.7...~.on...\.1¢n.»\-g.,9.u...-.--.-we-p~
`
`
`
`
`K"-\-ur......o-_-.....\.:_...._..-..m:_..f.:.._..._.._.q_«m-.»_-'.-o.-_
`
`
`
`818
`
`Coating
`
`and DeKay have reported that CAP
`gives excellent results in all tests for
`enteric properties.”
`Cellulose acetate phthalate is applied.
`to tablets as a solution in volatile organic
`solvents" such as ethylacetate-BA "de-
`natured alcohol solution.” Tablets that
`have been coated with this material may
`be sealed with a coating of wax to i_m-
`prove water irnpermeability. Cellulose
`acetate phthalate when combined with
`polyethylene glycol has also been used as
`a water soluble filrn coating. The use of
`starch and amylose acetate phthalate as
`an entericcoating material has also been
`reported,“
`Lipids—These have been combined
`with other ingredients to give favorable
`enteric coatings One such combination is
`a mixture of myristic acid, hydrogenated
`castor oil, castor oil, cholesterol and
`sodium taurocholate.“ The. mixture is
`dissolved in ethylene dichloride, benzene,
`absolute ethyl alcohol for application.
`Coating mixtures _containing lipids such
`as waxes or hydrogenated oils in com-
`binations with fillers may be_ granulated
`and applied to core tablets by compres-
`sion coating.
`'
`Synthetic Resins--—Resins have been
`applied as enteric coatings on a com-
`nierical basis and in general are applied
`as a solution in volatile solvents Among
`the "resins that have been proposed as in-
`gredients in various coating formulations
`are polyvinyl acetate -phthalate; phenolic
`anhydride, styTene—maleic acid copoly-
`liners, and poly (methylvinyl ether) X
`maleic anhydride.
`
`swelling, are incorporated to bring about
`disintegration in 6-8 hours. ‘7
`A comprehensive compilation of pro-
`cedures
`materials suitable for pro.
`ducing sustained release and timed re-
`lease dosage forms and based on patent,
`literature is available to the student. 18
`
`Exiemporuneous Melhocls
`
`Wlfile the coating of dosage forms such I
`as tablets is a process best performed by
`manufacturing companies, it is possible
`for the pharmacist to coat these dosage
`forms extemporaneously if the pr-ope};
`materials and methods are used.
`Some traditional methods, such as the
`use of phenyl salicylate (salol) or the
`dipping of capsules‘ into formaldehyde
`solution for the extemporaneous enteric
`coating of capsules, have fallen into dis-
`favor because of the unreliability of the
`coatings.
`'
`For a convenient and satisfactory ex-
`temporaneous enteric coating for tablets,
`capsules, or pills, the following process”
`may be used. A mixture composed of n-
`butyl stearate (.45 parts), carnauba wait
`(30 parts), and stearic acid (25 parts), is
`heated on a water bath to 75°C. The
`tablet, pill, or capsule is held at one end
`with tweezers and dipped into the liquid.
`As the object is Withdrawn, the coating
`solidifies rapidly. After the coating of
`each of the capsules, or other dosage
`form, in this manner, the uncoated end.
`is then dipped in the melted mixture to a
`depth that will give an overlap of the
`coating material over
`the previously
`coated end. Two coats are suflicient. In
`
`Approximately
`tion per 25 ca}:
`sules in a 400
`then swirled ur
`and become ta:
`of the coating s
`ing of the bea
`cedure is repes
`been applied.
`tossed onto ga-
`to air dry for
`This techniqut
`withstand imrr
`fluid TS for 3 I
`lated intestine
`hour.
`
`Ammonium Cli
`(Enteric co
`DTD NI
`1 tab ti
`
`Sig:
`
`Aspirin
`M ft enter.
`Dispense
`Sig: One q -
`
`En-seals Sodiuri
`DTD N
`Sig: One ta
`
`'l'e-sling and
`Coated do:
`
`by in vitro an
`disintegratior
`With the pres
`logical availa
`forms, it is 1
`effect of a coa
`
`by both in vi"
`Particularl
`lease coating
`ment among
`the relative
`coating mate
`ment is due '
`materials, ti
`and to the
`used to dete
`
`coatings. Ph
`stomach em]
`
`Materials for Timed Disiniegraiion
`
`Coatings which disintegrate.a:i'ter a
`certain length of time in the gastrointes-
`tinal tract regar_dless of the acidity or
`alkalinity of h the digestive fluids are
`readily utilized for timed release or sus-
`tained action dosage forms. One such
`coating is composed of stearic acid,
`carnauba wax, petrolatum, powdered
`agar,
`pow-dered elm bark. The elrn
`bark and agar, because of their property
`of absorbing moisture with resultant
`
`‘
`
`addition to the use of tweezers, a needle
`may be used to dip capsules or pills into
`the melted mixture, care being taken to
`insure a complete coverage of the capsule
`or pill after the" needle is removed.
`Another extemporaneous method for
`enteric coating of capsules utilizes poly-
`vinyl acetate polymers. 1" The recom—
`mended formula is:
`
`Vinac ASB-10 or Gelva 0-3
`Castor Oil
`Acetone
`
`10-12%
`10% 0/”
`so~7s% v/v
`
`,.:¢,r.§3h¢..<.:9..~i4gam!.(.-'-.;¢L...-an:-.—-;—mI.L.v-\.v\:~I..'.w-m£¢r_=:h.-2.
`
`Amerigen Ex. 1060, p. 9
`Amerigen Ex. 1060 9
`
`
`

`
`Approximately 2 ml of the coating solu-
`tion per 25 capsules is added to the cap-
`sules in a 400-600 ml beaker which is
`then swirled until the capsules are coated
`and become tacky. A second 2 ml portion
`of the coating solutiof. is added and swirl-
`ing of the beaker is repeated. The pro-
`cedure is repeated until 8-10 coats have
`been applied. The capsules are then
`tossed onto gauze or a towel and ‘allowed
`to air dry for 8-12" hours or overnight.
`This technique produced capsules which
`withstand immersion in simulated gastric
`fluid TS for 3 hours and dissolve in simu-
`lated intestinal fluid TS in less than 1
`hour.
`
`5
`
`Ammonium Chloride
`(Enteric coated tablets)
`DTD No 30 .
`1 tab tid
`
`Sig:
`
`'6
`
`gr viiss
`
`Aspirin
`M ft enteric coated capsules
`Dispense 25 such capsules
`Sig: One q 4 hours as needed
`
`7
`
`Enseals Sodium Salicylate (Lilly)
`DTD No. 30
`Sig: One tablet two times a day
`
`griiss
`
`grx
`
`Testing and Evaluation
`
`Coated dosage forms may be tested"
`by in vitro and in viva methods for both
`disintegration and dissolution
`rates.
`With the present emphasis on the physio-
`logical availability of drugs from dosage
`forms, it'is necessary to determine the
`effect of a coating on the release of a drug
`by both in vitro and in viva methods.
`Particularly with enteric and timed re-
`lease coatings,
`there is some disagree-
`ment among various investigators as to
`the relative value of different types of
`coating materials. Much of the disagree-'
`ment is due to variations in the coating
`materials,
`the methods of application,
`and to the dissimilarity of techniques
`used to determine the efliciency of the
`coatings. Physiological factors such as
`stomach emptying time and absorptive
`
`Coating
`
`819
`
`sites of the gastrointestinal tract also
`contribute to disagreements in the evalu-
`ati on of enteric coatings.
`To insure batch uniformity in control
`procedures, in. vitro methods may be used
`to determine disintegration and dissolu-
`tion rates and automated methods for
`prolonged determination of dissolution
`rates have been devised“ which may be
`adapted for this purpose.
`- Determination of
`the efficiency of
`coatings by in vitro tests involves the use
`of simulated digestive fluids. An official
`test for plain coated and enteric coated
`tablets is provided in the USP. Plain
`coated tablets are first immersed in water
`for 5 minutes then immersed in simulated
`
`gastric fluid for 30 minutes. If the plain
`coated tablets have not disintegrated fol-
`lowing the exposure to simulated gastric
`fluid they are then immersed in simu-
`lated intestinal fluid. The tablets should
`disintegrate in a total tinle equal to the
`time specified for plain coated tablets in
`the USP monograph plus 30 minutes.
`Enteric coated tablets should show no
`evidence of disintegration or solution
`when subjected to simulated gastric fluid
`for 1 hour. They should, however, disin-
`tegrate when subjected to simulated in—
`testinal fluid for a time equal to 2 hours
`plus the time specified in the oflicial indi-
`vidual monograph for the plain coated
`tablet or, where only an enteric coated
`tablet is recognized, for the time limit
`specified in the monograph.
`Simulated gastric fluid of the USP has
`a pH of about 1.2 and is composed of
`sodium chloride, pepsin, hydrochloric
`acid and distilled water. Simulated in-
`testinal fluid of the USP contains mono-
`basic potassium phosphate, pancreatin,
`distilled water, and 0.2 N sodium hy-
`droxide. It is adjusted to a pH of 7.5.
`The USP also provides an official pro-
`cedure for the determination of dissolu-
`
`tion rates for tablets and capsules. Vari-
`ous methods, similar in nature to the
`USP method, have been devised to mea-
`sure dissolution of drugs from coated tab-
`lets and capsules which in turn permit
`the evaluation of the specific coating ma-
`
`Amerigen Ex. 1060, p. 10
`
`

`
`
`
`820
`
`Coating
`
`terials. In general, the various methods
`have modifications in the dissolution
`
`medium and in the extent and type of
`agitation.
`The i_.t_nportance of in vivo disintegra-
`tion time of
`tablets whether
`sugar -
`coated or- enteric coated, as related to
`the active ingredient has been shown by
`the fact that riboflavin in sugar coated
`tablets requiring two hours for in vitro
`disintegration by the USP test does not
`guarantee that it will be fully physio-
`logically available to all people.”
`Snce barium sulfate is opaque to X-
`rays, it may be used in experimental
`enteric coated products so that the be-
`havior of the product in the gastroin-
`testinal
`tract may be deterrnined by
`roentgenoscopy or roentgenography. At
`various time intervals the position and
`condition" of the enteric coated product
`may be determined with disintegration
`being indicated by a scattering of the
`barium sulfate. This procedure is quite
`suitable for comparative testing of differ-
`ent enteric coating materials.
`An in vivo method utilizing radioactive
`sodium in the form of sodium chloride
`
`has been reported.“ Passage of enteric
`coated capsules containing the radio-
`active material
`through the gastroin-
`testinal tract can be followed with a
`Geiger counter. Since disintegration of
`the coated product is determined by the
`appearance of radioactivity in the hand
`of the subject, the site of disintegration
`cannot be well defined.
`
`In. vino disintegration tests are suitable
`for comparative evaluation of coating
`materials but further in oiuo tests must
`be conducted to determine the influence
`
`of the coating on the absorption or physi-
`ological availability of the drug. This
`testi_ng includes such methods as the
`measurement of the concentration of a
`
`drug in the blood at periodic time inter-
`vals or the measurement of urinary ex-
`cretion of a drug.
`
`Dispensing Couied Products
`
`Coated tablets or capsules should be
`dispensed in glass or plastic vials to pro—'
`tect
`them from the atmosphere and
`hL1.midity. Particularly in the case of ex-
`temporaneously coated products, proper
`care should be taken to avoid either
`cracking or breaking the coating.
`
`References
`
`1. Tucker SJ, Rednick AB: JAPhA, Sci
`Ed 493738, 1950.
`2. Lachman L, Cooper J: J Pharm, Sci 52:
`490, 1963.
`3. Mody DS, Scott MW, Lieberman HA:
`J Pharm Sci 53:949, 1964.
`4. Doerr DW, Serles EH, Deardorff DL:
`JAPhA, Sci Ed 43:433, 1954.
`5. Gans EH, Chavkin L: JAPhA, Sci Ed
`43:483. 1954.
`6. Golod WH, Huyclr CL: Drug Cos Incl
`77:620, 1955.
`7. Wurster DE: JAPhA, Sci Ed 483151,
`1959.
`8. Wruble M: JAPhA 24:570, 1935.
`9. Wagner JG, Ryan GW, Kubiak E,
`Long S: JAPRA, Sci Ed 49:133, 1950.
`10. Goorley JT, Lee CO: JAPhA 27:379,
`1933.
`11. Bauer CW, Masucci PE: JAPhA, Sci
`Ed 37:124. 1948.
`12. Hodge HC, Forsyth IIH, Jr, Ramsey
`GII: J Pharmacol Exptl Ther 80:241, 1944.
`13. Antonides IIJ, De.Kay HG: Drug Std
`21:205, 1953.
`14. Huyck CL: JAPhA, Prac Ed 7:86,
`1946.
`
`15. Wagrier JA, Brignall TW, Long S:
`JAPhA_. Sci Ed 43:244, 1959.
`16. Maney PV, Kuever RA, JAPhA, Sci
`Ed 30:276. 1941.
`17. Worton AG, Kempf GF, Burrin PL,
`Bibbius FE: JA.Ph.A 27:21, 1938.
`18. Williams A: Sustained Release Phar-
`maceuticals. Park Ridge NJ, Noyes Develop-
`ment Corp, 1969.
`19. Stoklosa MJ, Ohmart LM: JAPhA, Pr
`Eol 14:507, 1953.
`20. Cook CI-I, Webber MG: Am J Hosp"
`Pharm 22:95, 1965.
`21. Schroeter LC, Hamlin WE: J Pharm
`Sci 52:811, 1963.
`22. Morrison AB, Chapman DG, Camp-
`bell JA: JAPIFIA, Sci Ed 48:634, 1959.
`23. La.rk—I-Iorovitz K, Lang HR: JAPhA,
`Sci Ed 31 :99, 1942.
`
`Amerigen Ex. 1060, p. 11
`Amerigen Ex. 1060, p.
`L,,....
`
`:11
`
`Derm
`
`
`
`Dermatologi:
`are applied t
`protective fi
`
`Dermatolt
`
`liquid, solid,
`rations.
`
`Liquid Derl
`
`From a 1
`liquid dermz
`any other l
`they may 83
`or colloidal
`
`and supplen
`ous, hydroal
`ally oily) v
`liquids are
`permits a s
`vehicles. Fr
`
`polyethylen
`isopropanol
`ethyl ethei
`
`.4...~,.-.-,..:we-»..u.wa.n,i.¢«9.»u.u.,m«»..-:.w~3«._.-—a..—-1..-«r.-=-

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket